Evidence map›Paper›PMID 42128908›Full record

ArticleNature biomedical engineering2026

Liposomal nanoprobes actuated by engineered water channels for sensitive detection of molecular targets by MRI.

Sayani Das, Jacob Cyert Simon, Miranda Dawson, Vinay K Sharma, Samira M Abozeid, Gregory D Thiabaud, Grace Sun, Sarah Bricault, Itay Fayer, Yuting Ke and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sayani Das *Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-0206-9223
Jacob Cyert Simon *Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-7683-9839
Miranda DawsonDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-3226-9122
Vinay K SharmaDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Samira M AbozeidDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Gregory D ThiabaudDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5189-8445
Grace SunDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4896-2527
Sarah BricaultDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-0832-7855
Itay FayerDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Yuting KeDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-0755-0737
Jeong Hoon KoDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
LiLi FinchDepartment of Neuroscience, Wellesley College, Wellesley, MA, USA.
Kyle BackmanDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Sajal SenDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Takashi KaiseDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Yuri TakadaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-7955-6567
Hiroaki ItohGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-1329-6109
Masayuki InoueGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-3274-551X
Alan JasanoffDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. jasanoff@mit.edu.ORCID http://orcid.org/0000-0002-2834-6359

Funding

Nanosensors for sensitive brain-wide neurochemical imagingR01NS120592 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JASANOFF, ALAN · 2021 to 2021
$1.4M
Supplement to Neurobiological Engineering Training ProgramT32EB019940 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JASANOFF, ALAN · 2015 to 2025
$1.4M
Nanoprobes for neurotransmitter-sensitive molecular fMRI in addiction researchR21DA044748 · NIDA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JASANOFF, ALAN · 2017 to 2018
$387k
G. Harold and Leila Y. Mathers Foundation (G. Harold & Leila Y. Mathers Foundation) n/aHuman Frontier Science Program (HFSP) HFSP postdoctoral fellowshipNIBIB NIH HHS T32 EB019940NIDA NIH HHS R21 DA044748NINDS NIH HHS R01 NS120592
6 · The paper itself

Abstract

Monitoring biochemical processes requires tools to detect specific molecular species in vivo. Although responsive probes detectable by MRI enable this, conventional MRI contrast agents often lack sufficient sensitivity. Here we circumvent this limitation using nanoscale probes constructed from pore-forming peptides incorporated into paramagnetic liposomes. In our design, target molecules control MRI contrast by regulating water access to liposome-encapsulated gadolinium chelators. The large ratio of gadolinium complexes to pores provides a sensitivity gain by over an order of magnitude compared with small-molecule MRI sensors. We demonstrate the probe architecture using biotin as a model analyte and gramicidin A as the basis for responsive pores. We then validate the biotin-sensitive liposomal probes in vitro and in rat brain, and we show that minimally invasive delivery to multiple tissue types is feasible. Furthermore, we identify pore sequences that provide greater MRI contrast effects than native gramicidin and we demonstrate that further channel modifications permit detection of different target molecules. This work thus introduces a potent and engineerable technology for molecular imaging in living systems.

Identifiers

PMID42128908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.